PT  - JOURNAL ARTICLE
AU  - Rizzo, Toni
ED  - Chieffo, Alaide
TI  - TAVI with Balloon and Self-expandable Devices: Results from the Milan Registry
DP  - 2012 Dec 01
TA  - MD Conference Express
PG  - 10--11
VI  - 12
IP  - 8
4099  - http://mdc.sagepub.com/content/12/8/10.short
4100  - http://mdc.sagepub.com/content/12/8/10.full
AB  - Transcatheter aortic valve implantation (TAVI) is a viable treatment option for high-risk surgical patients with severe symptomatic aortic stenosis (AS). The SAPIEN XT™ (SXT) and CoreValve® with AccuTrak™ delivery system (MCVAT) are new generation devices currently available in Europe for transfemoral TAVI. To date, no prospective comparisons between these 2 devices have been undertaken. The objectives of this study were to assess the overall clinical outcomes of TAVI and to compare the SXT versus MCVAT devices in a nonrandomized registry population.